CHENNAI: Orchid Chemicals and pharmaceuticals has entered into a licensing and distribution agreement with pharma company Actavis for marketing its generic formulations in Europe. Under the agreement, Actavis will market nine of its anti-infective Cephalosporin generic formulations in 37 countries of Europe. Orchid will develop and manufacture nine cephalosporin formulations in specific dosage forms and strengths for licensing to and marketing by Actavis in Europe, a company release said on Thursday.
Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More